Discontinuation of benralizumab in Canadian patients with severe eosinophilic asthma

• Stephen G. Noorduyn,
• Karissa Johnston,
• Kathy Osenenko,
• Niroshan Sriskandarajah,
• Alain Gendron,
• Lawrence Mbuagbaw

Affiliations

Stephen G. Noorduyn

AstraZeneca Canada Ltd, Mississauga, ON, Canada

Karissa Johnston

Broadstreet HEOR, Vancouver, BC, Canada

Kathy Osenenko

Broadstreet HEOR, Vancouver, BC, Canada

Niroshan Sriskandarajah

AstraZeneca Canada Ltd, Mississauga, ON, Canada

Alain Gendron

Dept of Medicine, University of Montreal, Montreal, QC, Canada

Lawrence Mbuagbaw

Dept of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, ON, Canada